Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118445786 | 11844578 | 6 | F | 20151210 | 20160727 | 20151217 | 20160728 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201512004459 | ELI LILLY AND CO | 70.77 | YR | F | Y | 58.00000 | KG | 20160728 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118445786 | 11844578 | 1 | PS | FORTEO | TERIPARATIDE | 1 | Subcutaneous | 20 UG, QD | 21318 | 20 | UG | INJECTION | QD | ||||||
| 118445786 | 11844578 | 2 | SS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 118445786 | 11844578 | 3 | C | NEO-MINOPHAGEN C | AMMONIUM GLYCYRRHIZATE | 1 | Intravenous (not otherwise specified) | 60 ML, 3/W | 0 | 60 | ML | INJECTION | TIW | ||||||
| 118445786 | 11844578 | 4 | C | URSO | URSODIOL | 1 | Oral | 200 MG, TID | 0 | 200 | MG | TABLET | TID | ||||||
| 118445786 | 11844578 | 5 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | TABLET | QD | ||||||
| 118445786 | 11844578 | 6 | C | DEPAS | ETIZOLAM | 1 | Oral | 0.5 MG, QD | 0 | .5 | MG | TABLET | QD | ||||||
| 118445786 | 11844578 | 7 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 50 MG, QD | 0 | 50 | MG | TABLET | QD | ||||||
| 118445786 | 11844578 | 8 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 118445786 | 11844578 | 9 | C | ALDACTONE A | SPIRONOLACTONE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118445786 | 11844578 | 1 | Osteoporosis |
| 118445786 | 11844578 | 2 | Pneumonia |
| 118445786 | 11844578 | 3 | Hepatic cirrhosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118445786 | 11844578 | OT |
| 118445786 | 11844578 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118445786 | 11844578 | Acute kidney injury | |
| 118445786 | 11844578 | Hepatic failure | |
| 118445786 | 11844578 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118445786 | 11844578 | 1 | 20151203 | 20151209 | 0 | |
| 118445786 | 11844578 | 2 | 20151211 | 0 |